Home
Companies
Catalysts
Deep Dives
Generalized lipodystrophy
GL · Rare Disease · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
Drug
Company
Mechanism
Modality
Route
Stage
Mibavademab
REGN
LEPR agonist (monoclonal antibody)
Monoclonal antibody
SC
PHASE3
Indications (1)
Generalized lipodystrophy
Mibavademab
PHASE3
Data from Supabase · Updated 2026-03-24